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Introduction
Controlled drug delivery occurs when a matrix, usually a
polymer, whether natural or synthetic, is opportunely com-
bined with a drug or other active agents in such a way that
the active agent is released from the material in a controlled
manner. The goal of many of the original controlled-release
systems was to achieve a delivery profile that would yield a
high blood level of the drug over a long period of time. The
key point with traditional drug administration is that the
blood level of the agent should remain between a maximum
value, which may represent a toxic level, and a minimum
value, below which the drug is no longer effective. In con-
trolled drug-delivery systems designed for long-term admin-
istration, the drug level in the blood should remain constant
within the desired range for an extended period of time.
Controlled-delivery systems offer other advantages, for ex-
ample, the need for fewer administrations, optimal use of
the specific drug, and increased patient compliance. These
advantages can be all significant, but the potential disadvan-
tages cannot be ignored: the possible toxicity or non-bio-
compatibility of the materials used, undesirable byproducts
of degradation, any surgery required to implant or remove
the system, the chance of patient discomfort from the deliv-
ery device and the higher cost of controlled-release systems
compared with traditional pharmaceutical formulations. The
ideal drug-delivery system should be inert, biocompatible,
mechanically strong, comfortable for the patient, capable of
achieving high drug loading, safe from accidental release,
simple to administer and remove and easy to fabricate.
Some of the drug carriers currently in use include soluble
polymers, microparticles made of insoluble or biodegradable
natural and synthetic polymers, microcapsules, cells, lipopro-
teins, liposomes and micelles. Recently silica matrices have
been investigated for encapsulation of biomolecules such as
enzymes, antibodies and cells.[1,2] Silica matrices show high
biocompatibility–biodegrability[3–5] and resistance to micro-
bial attack and they exhibit higher mechanical strength, en-
hanced thermal stability and negligible swelling in organic
solvents, compared to most organic polymers. All these fea-
tures make silica supports promising carriers for the drug-
delivery systems formulation. Several research groups have
investigated both drug storage and delivery properties of or-
dered mesoporous silica[6–10] and of sol–gel silica materi-
als.[11–13] A major advantage in the use of a sol–gel is that the
matrix can be generated in the presence of the drug mole-
cule in a one-step process; moreover, the physicochemical
features of silica could be suitably modulated by the control
and the opportune variation of the parameter process (com-
position of precursor mixture, catalysts, pH, ageing). Re-
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cently we have examined the delivery behaviour of ibupro-
fen from hybrid inorganic–organic silica carriers.[14,15] In par-
ticular we have obtained promising results from silica matri-
ces modified with methyl groups prepared by a sol–gel ap-
proach. With the addition of these organic functions, we
have decreased the amount of surface silanol groups, leading
to a more hydrophobic surface that allows an effective con-
trol of the ibuprofen release: in fact, in this case, it is very
close of that expected for an ideal drug-delivery system
(slow and gradual). Unfortunately with these matrices we
have obtained only a partial release (70 wt%) of the total
drug initially loaded. It is, instead, desirable, to achieve a
gradual drug release and at the same time characterised by
a highest amount of the delivered drug. In the present study,
the silica structure is modified with the introduction of hy-
drophilic groups by using the (3-aminopropyl) triethoxysi-
lane (APTES) as precursor in a sol–gel process. APTES is
employed in many fields of the modern chemistry and tech-
nology for chemical modification of various oxide surfaces
and for surface coatings;[16] moreover, in this last decade
several reports have been published on its use as modifier
agent of porous silica employed as carriers for encapsulation
and delivery of pharmaceutical drugs.[14,17] However, to the
best of our knowledge, only a few studies[18] have been re-
ported, up to now, on hybrid amine–silica carriers prepared
by sol–gel methods used for the sustained release of drugs.
The modification with APTES changes dramatically the
physicochemical properties of the silica matrix affecting, in
particular, both reactivity and stability of the obtained mate-
rials in an aqueous medium. This aspect is very important
for a drug-delivery system in which the matrix degradation
can affect to a high degree the sustained release. Moreover,
the aminopropyl groups can increase the strength of interac-
tion between the functional groups and the drug molecule if
opportunely selected. It is worth noting that the hydrolysis
products of APTES elicit a sensitisation response neither
from at high dosage nor after long period of exposition and
administration: in fact, both in vivo and in vitro screening
assays have not revealed any evidence of genotoxic poten-
tial.[19] This consideration is very important in view of the
final application of the carrier here under investigation. The
goal of this work is the optimisation of a one-step sol–gel
process for the synthesis of hybrid amine–silica carriers for
the controlled release of ibuprofen. We have, in particular,
studied the optimal composition (amount of the functional
groups) of the final material, in order to obtain a gradual
and controlled release, but, at the same time, leading to a
high final amount of drug released.
Results and Discussion
100% Tetraethoxysilane (TEOS) silica matrix : All silica car-
riers studied in this work have been prepared by a one-step
synthesis following the sol–gel method. This low-tempera-
ture process offers several advantages: in particular, it as-
sures high homogeneity of the final products,[13] with the
possibility of various formation processes that allow the
strict control of the physicochemical properties of the final
systems. In the present work we have used ibuprofen with
tetraethoxysilane (TEOS) as silica source, following the pro-
cedure reported in previous work.[15] We have obtained a
monolithic silica/ibuprofen gel (Figure 1): it was limpid,
transparent and homogeneous, and was used as reference
frame. The amount of drug released from TEOS-derived
samples (expressed as % of ibuprofen on the total amount
of ibuprofen present) is shown as a function time in
Figure 2. The data were collected from a gel aged for ten
days, the time necessary to obtain a stable carrier.[15] The de-
livery profile exhibits a pronounced initial release of 50%
of ibuprofen under 30 min followed by a slightly slower re-
lease rate. A kinetic of this type is not proper for a con-
trolled delivery system that should gradually release drugs
Figure 1. Picture of a silica/ibuprofen tablet
Figure 2. Ibuprofen delivery from 100% TEOS carrier and from modified
samples. Comparison of the experimental release with the profile as-
sumed for an ideal drug-delivery system (dashed line).
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at a constant rate, thereby maintaining (in vivo) drug con-
centration within the therapeutic range and thus eliminating
the need for frequent re-dosages. However, this is not sur-
prising: in fact, drug release is generally known to be rela-
tively fast in TEOS-based xerogel without dopant.[4] The lib-
eration process of a drug from a solid carrier is essentially
governed by both matrix dissolution and diffusion,[3] which
are strictly connected with the physicochemical properties
of the matrix itself. In particular, both hydrophilic/hydro-
phobic character of the matrix and the nature of interaction
between the embedded molecule and the surface of the car-
rier play a key role. In the case of the TEOS-derived silica
matrix, ibuprofen can interact with the few surface silanol
groups only by weak interactions (mainly by hydrogen
bonding) and this could probably explain its fast release ki-
netic (Scheme 1). We checked if this speculation could be
supported by any experimental evidence: for this reason,
FTIR spectroscopy of the powders themselves has been re-
sorted to in order to investigate the nature of the TEOS/ibu-
profen interaction. The 100% TEOS matrix exhibits the
known spectroscopic features (see curve 1 in Figure 3), typi-
cal of a plain silica-based system.[20] In particular, in the
3850–2500 cm1 range it is possible to observe some peculiar
bands that can be assigned to:
1) The stretching vibration of surface OH groups at n
3735 cm1, free from hydrogen bonding interactions.
2) An intense and broad band, located in the 3700–
2750 cm1 range, originating from the stretching vibra-
tion of OH groups mutually interacting by hydrogen
bonding.
The activation treatment of the sample influences the hy-
dration state of the surface: in fact, a gradual reduction of
water either physisorbed and/or coordinated to the surface
of the SiO2 system, characterised by a signal at n
1630 cm1, due to the in-plane HOH bending mode (data
not reported for the sake of brevity), decreases increasing
the evacuation time.
We must consider also the important absorptions present
at n<2100 cm1. These bands can be attributed, on the basis
of their spectral behaviour and of the literature,[21] to Si-O-
Si combination (overtones) modes characteristic of the silica
matrix. When ibuprofen is added to the pure TEOS system
(see curve 2 of Figure 3), some important spectroscopic
changes are evident due to the presence of the drug. In par-
ticular:
1) At high frequency, in the 2750–3100 cm1 range, sharp
bands appear: their spectral behaviour permits to assign
them to nCH stretching modes of all CH-containing spe-
cies (spectra 2 and 3 in Figure 3) present in the ibuprofen
molecule (i.e., of either aliphatic or aromatic nature).
2) At low frequency (n<1800 cm1) intense and broad
bands are observed: these represent either the spectral
bending (dCH) counterparts of the above-described
stretching modes of all CH-containing species or the nCO
(1695 cm1) of the carboxylic residue present in the
drug.
As a reference, we reported in Figure 3 the IR spectrum
obtained for the pure drug. It is straightforward that there is
an almost total overlap between the spectroscopic assign-
ment of the several components which the TEOS+ ibupro-
fen system exhibits and those present in the plain ibuprofen
sample. However, all the above components are better visi-
ble in the (21) trace reported in Figure 3, which represents
the difference obtained by subtracting spectrum of plain
TEOS from that of the TEOS+ ibuprofen system. What is
worth noting is the intense negative (i.e. , it represents a spe-
cies that is not present on the system anymore, because it
has been “consumed”) peak located at 3740 cm1: this ex-
perimental evidence is vital in confirming that ibuprofen in-
teracts with the silica surface through the OH species.
APTES/TEOS samples
Synthetic procedure optimisation : To increase the drug–sur-
face interactions, but, at the same time, modifying the sur-
Scheme 1. Example of interaction between ibuprofen and the silanol
groups on the silica surface
Figure 3. Absorbance FTIR spectra in the 3950–1300 cm1 range relative
to several samples outgassed at beam temperature for one hour: curve 1:
100% TEOS; curve 2: TEOS+ ibuprofen; curve 3: pure ibuprofen mixed
with KBr (1:1 ratio). The (21) trace refers to a differential absorbance
spectrum obtained by subtracting curve 1 (100% TEOS) from curve 2
(TEOS+ ibuprofen).
Chem. Eur. J. 2009, 15, 12043 – 12049  2009 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemeurj.org 12045
FULL PAPEROrganic–Inorganic Hybrid Composites
face reactivity (hydrophilic character, wettability, etc.) of the
silica, we have prepared an organic–inorganic hybrid matrix
by introducing (3-aminopropyl)triethoxysilane (APTES) as
precursor in the sol–gel process. Initially we studied a 100%
APTES silica gel and we obtained a monolithic and homo-
geneous silica/drug carrier. Unfortunately this sample is ab-
solutely unsuitable to sustain and control a real drug deliv-
ery. In fact, as expected, it is soluble in aqueous solution
and it dissolves completely after few minutes of contact with
the physiological medium. As reported by Suratwala ,[22] the
gel-to-sol transition is essentially due to the dissolution of
the siloxane cross-links (the break-up of Si-O-Si bonds by
hydrolysis during the re-esterification reaction for which the
aqueous solution has easy access) that increases with both
pH and temperature of the dissolution medium. High cross-
link densities decrease the ability for dissolution and this
could be achieved by introducing a second component. To
increase the chemical stability of the amino-substituted
silica we modified the initial synthesis by using a mixture of
TEOS and APTES as starting precursors. The new synthesis
is fast and relatively easy relative to that used to synthesise
the 100% TEOS matrix. APTES catalyses the process as an
initiating species in the sol–gel reaction: in its absence, hy-
drolysis and poly-condensation proceed very slowly, lasting
weeks instead of a few minutes. The presence of APTES fa-
vours the formation of cyclic intermediates, reported in
Scheme 2, that probably provides an energetically favoura-
ble reaction path.[16] Cyclic intermediates formed during the
hydrolysis/condensation reactions of an APTES–TEOS mix-
ture speed up the hydrolysis and allow us to obtain the gel
carriers without using acid catalysis. We have prepared sam-
ples with increasing APTES amount in the gel composition,
as reported in Table 1.
The difference in the reactivity (hydrolysis/condensation)
of the two alkoxides (TEOS and APTES; T/A system) has,
anyhow, requested a remarkable effort in order to obtain a
homogeneous gel. In fact, in the first stage of the study,
after water addition to the mixture of the precursors, we ob-
tained a precipitate: after the optimisation of the H2O/alk-
oxide ratio and the order of addition of reactants (the water
is added in the final stage of the process with the opportune
amount of drug), we obtained a monolithic and homogene-
ous gel, requiring only few minutes for its formation. Un-
fortunately, for the lowest and highest amounts of APTES
in the initial mixture (80T/20A and 50T/50A carriers), the
final systems appear un-homogeneous and breakable. In
these cases the reaction rates of the two alkoxides are not
well matched (TEOS is much more resistant to the hydroly-
sis) and this determines the only partial reticulation of the
silica matrix producing the un-homogeneity. This feature is
very marked in the tablets derived from the lower percent-
age of APTES (80T/20A), which are made of white islands
of soft consistency with a large amount of supernatant
liquid. In the light of this evidence, the 80T/20A sample will
not be considered for further investigation. FTIR spectros-
copy has been resorted in order to get some information
about the surface of the synthesised systems and about the
nature of interactions between the ibuprofen molecule and
the silica; the results are reported and discussed in the next
section.
FTIR spectra of modified systems : The FTIR spectra of the
samples, in which the silica matrix has been modified by the
presence of APTES, are reported in Figure 4. The OH pat-
tern of these systems is very different from that of the pure
TEOS material, because of the presence of the APTES
compound. In fact, it is possible to observe the absence (of
almost all) of the signals generated by the stretching mode
due to free OH (silanols) groups located at about
3745 cm1: compare curve 1 to curves 2 and 3 in Figure 3. In
contrast, an intense and broad band, generated by OH
groups interacting through hydrogen bonding, is present in
the 3500–2400 cm1 range. However, some other IR compo-
nents dominate the spectra of the mixed T/A materials. On
the basis of their spectral behaviour and of the litera-
ture ,[21, 23] these bands can be attributed as follows:
Scheme 2. Cyclic intermediate formed during the hydrolysis/condensation
reactions of APTES–TEOS mixture.
Table 1. Molar ratio of precursors in the samples.





[a] A:APTES; T:TEOS; the ratios are listed in the sequence TEOS/
APTES.
Figure 4. Absorbance FTIR spectra in the 3950–1300 cm1 range relative
to several samples outgassed at beam temperature for one hour: curve 1:
100% TEOS; curve 2: 70T/30A; curve 3: 50T/50A; curve 4: 100%
APTES.
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1) In the 3400–3150 cm1 range the sharp components refer
to both symmetric and asymmetric stretching nNH modes
of all surface NH-containing species.
2) At lower frequency, 3100–2750 cm1, the spectral compo-
nents are due to the stretching nCH vibration modes of all
CH-containing species.
3) The bands located at n<1800 cm1 represent the spectral
deformation d counterparts of either NH- or CH-con-
taining species above described.
The new spectral components can be due to the presence
of APTES (curve 4 in Figure 4): in fact, this molecule (see
Scheme 2) contains several organic groups (-NH2, -CH2,
-OC2H5 groups) which can justify the above assignments.
Moreover, it is interesting to note that the characteristic
silica overtones, located in the 2100–1600 cm1 range, are to-
tally absent in the mixed 50T/50A system (curve 3 in
Figure 4): this might mean that the silica structure is either
not preserved during the gelation procedure or the matrix
itself failed to form.
When ibuprofen is added to the mixed T/A systems, dif-
ferent characteristics are evident as a function of the T/A
ratio: in fact, only in the case of the 70T/30A material can
one observe the typical spectral features of the drug besides
those of the silica-based system (see curve 1 in Figure 5).
Among the several IR components now present, at least
three envelopes deserve some attention:
1) The bands indicated by the nNH in Figure 5 are residual
of the APTES presence in the 70T/30A+ ibuprofen
mixed system, even in the presence of the drug. Under
the same conditions no such absorptions are evident in
curve 3 (which refers to the 50T/50A+ ibuprofen
system): only a broad component in the 3700–2900 cm1
region is observed in this case, most likely due to the nOH
OH species involved in hydrogen-bonding .
2) In the 3100–2700 cm1 spectral range, a complex absorp-
tion is present for both A/T+ ibuprofen systems: this is
due to the nCH of all CH-containing species present in
the materials.
3) At n<1800 cm1, only in the case of the 70T/30A+ ibu-
profen mixed system, some of the bands typical of either
the drug or the APTES modifier are evident. These
bands have been described in the above sections and are
due to the deformation modes of either NH- or CH-con-
taining species.
None of these spectral components are observed for the
50A/50T+ ibuprofen materials: this might mean that for this
system there is no real interaction between the silica matrix
and the drug itself. The FTIR results obtained in the case of
the 60T/40A systems are consistent, without significant dif-
ferences, with that reported for the 70T/30A sample. The
drug release behaviour from these carriers will be discussed
in the following paragraph.
Drug release : Dissolution tests were carried out in vitro in a
simulated body fluid solution at pH 7.4 as reported in the
Experimental Section. In the figures the percentage of the
drug released is plotted as a function time. The delivery pro-
file from the 50T/50A system is un-controlled (very fast re-
lease rate) and absolutely not reproducible (consequently
not reported); these are indispensable requisites for its po-
tential application. This is not a surprising result and is cer-
tainly related to the physicochemical properties of this carri-
er. In fact, the absence of a well-defined silica structure and
of a real interaction between ibuprofen and the silica sur-
face, as confirmed by FTIR spectroscopy, leads to adverse
release behaviour that is not consistent with the aim of our
work. The drug-delivery profile from the modified silica car-
riers (70T/30A, 60T/40A) is shown in Figure 2, and it is com-
pared with the release curve of the 100% TEOS carrier. It
is worth noting that the results obtained with these systems
are absolutely reproducible and, moreover, after 1, 10 and
25 days of ageing the kinetic release is almost unchanged
(see Figure 6). This indicates the immediate (after 1 day
from their preparation) availability of the samples prepared
with the evident advantage derived in the case of a commer-
cial application. We can observe that the presence of
APTES in the gel composition has a significant effect in the
ibuprofen release leading to a continuous and gradual deliv-
ery profile, very similar for the two matrices investigated
(60T/40A; 70T/30A). This result is more evident if com-
pared with that obtained for the 100% TEOS derived
matrix. As known, the release of biologically active agents
from a porous matrix is mainly governed by a combination
of several processes, the influence of which on the final re-
lease behaviour varies case by case. Among these factors we
can name: 1) diffusion through the carrier matrix, 2) carrier
matrix erosion, 3) combined erosion/diffusion process and
4) the interaction between matrix and drug molecules. The
promising result achieved for our hybrid matrices can be as-
cribed to a combination of all these factors. Certainly the
Figure 5. Absorbance FTIR spectra in the 3950–1300 cm1 range relative
to several samples outgassed at beam temperature for one hour: curve 1:
70T/30A+ ibuprofen; curve 2: pure ibuprofen in KBr powder (1:1 ratio);
curve 3: 50T/50A+ ibuprofen.
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stronger electrostatic interaction between the carboxy
groups in the ibuprofen molecule and the amine groups on
the matrices surface (Scheme 3) lead to lower release rates.
On the other hand, a strong interaction between the matrix
and the drug can be detrimental and can impede the drug-
release process. In fact an essential requisite for a drug-de-
livery system is to maintain the drug concentration (in vivo)
within the range of the therapeutic efficacy and this goal
cannot be achieved if only a small fraction of the drug
loaded is delivered from the matrix over a relatively long
time. In the case of our matrices, the physiological solution,
favoured by the increased hydrophilic character, can easily
penetrate inside the pores, favouring the dissolution and dif-
fusion of the molecules of drug, surrounded by water; at the
same time the major wettability affects the silica dissolution
rate in the release medium with a direct influence on the
drug-delivery process. It is plausible that the liberation rate
is governed by the relationship between the rate of diffusion
and dissolution of the siliceous matrix. We can conclude
that the delivery profile from the 70T/30A and 60T/40T
samples is very similar to that expected from an ideal
system (see Figure 2): continuous, gradual and complete
(almost all drug loaded has been released).
Conclusions
In this study we have developed a reliable and reproducible
procedure for to design of a new controlled drug-delivery
system. By a one-pot sol–gel process we have prepared
silica/ibuprofen tablets functionalised by different amount of
aminopropyl groups and we have evaluated the effect of the
organic groups amount on the properties of the obtained
carriers (physicochemical properties, stability) and on drug-
delivery performance. The introduction of an opportune
quantity of organic groups allows good control of the hydro-
phobicity/hydrophilicity ratio and consequently on the drug-
delivery process, which is very similar to that expected from
an ideal system (gradual and continuous on the time) lead-
ing at the same time the release of almost all the drug ini-
tially embedded on the carrier. This is a very significant
result in the view of an effective commercial application of
the studied systems.
Experimental Section
Materials : Tetraethoxysilane (TEOS; Aldrich), (3-aminopropyl)-triethox-
ysilane (APTES; Aldrich), NaOH (Fluka), EtOH (Fluka), ibuprofen
sodium salt (Aldrich), Tris buffer saline (Fluka), HCl (Riedel-de Haen).
All reagents were used as received.
Synthesis of samples : Drug/silica composites were synthesised by a one
step sol–gel process. In a typical procedure the silica alkoxydes (TEOS
and/or APTES; 2 g) were combined with ethanol and ultra pure water
(0.5 mL addition of a few drops of HCl 0.01m in the case of 100% TEOS
matrix) in the required molar ratio (the molar ratio of precursors are re-
ported in Table 1). A solution of ibuprofen sodium salt (0.2 g) in water
(2 mL) was added to the obtained sol under continuous stirring in order
to favour the homogeneous dispersion of the drug in the final material.
Each individual sample was obtained by dispensing 1 mL of the sol into a
polyethylene cylindrical vial, the monolithic tablets were left to age in a
closed environment for 10 days at room temperature in order to ensure
the complete reticulation of the gel and to reach a constant weight
(200 mg). Each tablet (diameter: 1.0 cm; thickness: 0.5 cm) contains
50 mg of ibuprofen.
In vitro release : In vitro desorption of ibuprofen was studied in a saline
buffer solution at pH 7.4 (Tris Buffer). In a typical experiment, a silica/
ibuprofen tablet was soaked in the release fluid (10 mL) maintained at
37 8C. Samples of 1 mL were removed at predetermined time and re-
placed by the same volume of the fresh medium. The assays were per-
formed at room temperature with a liquid chromatographic system, Hew-
lett Packard Series 1100, equipped with an UV detector and with a
column LiChrospher 100 RP-18. The mobile phase consisted of 70% so-
lution (v/v) of acetonitrile in acidified water; the effluent was monitorat-
ed at 270 nm and the injection volume was 20 mL. The effective concen-
tration of ibuprofen in solution was calculated on the basis of Equa-
tion (1),[11] in which ceff is the corrected concentration at time t, capp is the
apparent concentration at time t, v is the volume of sample taken and V
is the total volume of dissolution medium.






Each release test was carried out three times by collecting, each time, the
data analysis simultaneously from two identical tablets.
Sample characterisation : FTIR spectra were obtained on a BRUKER
113v spectrophotometer (2 cm1 resolution, MCT detector). All samples
were inspected in the form of self supporting pellets (15 mgcm2). All
Figure 6. Ageing effect on the ibuprofen release rate.
Scheme 3. The interaction between the carboxy groups in the ibuprofen
molecule and the amine groups on the silica surface.
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samples were activated in controlled atmosphere at beam temperature
for one hour in quartz cells connected to a gas vacuum line (residual
pressure <1105 Torr; 1 Torr=133.352 Pascal), in order to get rid of
most of the physisorbed species (mainly H2O and contaminants weakly
interacting with the surface of the several oxidic systems here examined).
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